Seema Sheoran
Stock Analyst at Rodman & Renshaw
(2.54)
# 3,004
Out of 4,966 analysts
6
Total ratings
33.3%
Success rate
12.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Seema Sheoran
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals | Initiated Coverage: Buy | $12 | $2.78 | +331.65% | 1 | Jul 21, 2026 | |
| NGNE Neurogene | Initiated Coverage: Buy | $70 | $35.48 | +97.29% | 1 | Jun 3, 2026 | |
| AVXL Anavex Life Sciences | Initiated Coverage: Buy | $20 | $2.72 | +636.65% | 1 | May 4, 2026 | |
| CAMP Camp4 Therapeutics | Initiated Coverage: Buy | $7 | $4.25 | +64.71% | 1 | Apr 14, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $13 | $3.41 | +281.23% | 1 | Apr 2, 2026 | |
| SGMT Sagimet Biosciences | Initiated Coverage: Buy | $28 | $10.88 | +157.35% | 1 | Mar 26, 2026 |
Eledon Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $2.78
Upside: +331.65%
Neurogene
Jun 3, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $35.48
Upside: +97.29%
Anavex Life Sciences
May 4, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $2.72
Upside: +636.65%
Camp4 Therapeutics
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $4.25
Upside: +64.71%
SAB Biotherapeutics
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $3.41
Upside: +281.23%
Sagimet Biosciences
Mar 26, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $10.88
Upside: +157.35%